scholarly journals Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors

2017 ◽  
pp. now294 ◽  
Author(s):  
Shakti H. Ramkissoon ◽  
Pratiti Bandopadhayay ◽  
Jaeho Hwang ◽  
Lori A. Ramkissoon ◽  
Noah F. Greenwald ◽  
...  
2017 ◽  
Vol 19 (suppl_4) ◽  
pp. iv20-iv20 ◽  
Author(s):  
Pratiti Bandopadhayay ◽  
Shakti Ramkissoon ◽  
Jaeho Hwang ◽  
Lori Ramkissoon ◽  
Noah Greenwald ◽  
...  

2016 ◽  
Vol 18 (suppl 3) ◽  
pp. iii28.2-iii28 ◽  
Author(s):  
Pratiti Bandopadhayay ◽  
Shakti Ramkissoon ◽  
Jaeho Hwang ◽  
Lori Ramkissoon ◽  
Adrian Dubuc ◽  
...  

2017 ◽  
Vol 25 (8) ◽  
pp. 688-695 ◽  
Author(s):  
Lina Shao ◽  
Sue Miller ◽  
Carl Koschmann ◽  
Sandra Camelo-Piragua

Pediatric brain tumors are the leading cause of childhood cancer mortality. Recurring genetic abnormalities play an essential role in the diagnosis and prognosis of pediatric brain tumors. However, clinical workup has not routinely included whole genome assessment. Here, we present high resolution whole genome array results in 11 pediatric brain tumors. Array identified clinically relevant abnormalities in all samples. Copy number aberrations with targeted therapy implication, GOPC-ROS1 fusion, CDK4 amplification, and NF1 deletion, were detected in 3 cases. In addition, array detected recurring genetic abnormalities, including KIAA1549-BRAF fusion, 19q13.42 amplification, i(17q), and monosomy 6, which assisted accurate histological diagnosis in pediatric brain tumors. In conclusion, our results show that whole genome high-resolution array detects diagnostic and treatment-relevant copy number abnormalities in pediatric brain tumors.


2017 ◽  
Vol 188 ◽  
pp. 27.e1-27.e14 ◽  
Author(s):  
Bernard L. Marini ◽  
Lydia L. Benitez ◽  
Andrew H. Zureick ◽  
Ralph Salloum ◽  
Angela C. Gauthier ◽  
...  

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Yiqun Zhang ◽  
Fengju Chen ◽  
Lawrence A. Donehower ◽  
Michael E. Scheurer ◽  
Chad J. Creighton

AbstractThe global impact of somatic structural variants (SSVs) on gene expression in pediatric brain tumors has not been thoroughly characterised. Here, using whole-genome and RNA sequencing from 854 tumors of more than 30 different types from the Children’s Brain Tumor Tissue Consortium, we report the altered expression of hundreds of genes in association with the presence of nearby SSV breakpoints. SSV-mediated expression changes involve gene fusions, altered cis-regulation, or gene disruption. SSVs considerably extend the numbers of patients with tumors somatically altered for critical pathways, including receptor tyrosine kinases (KRAS, MET, EGFR, NF1), Rb pathway (CDK4), TERT, MYC family (MYC, MYCN, MYB), and HIPPO (NF2). Compared to initial tumors, progressive or recurrent tumors involve a distinct set of SSV-gene associations. High overall SSV burden associates with TP53 mutations, histone H3.3 gene H3F3C mutations, and the transcription of DNA damage response genes. Compared to adult cancers, pediatric brain tumors would involve a different set of genes with SSV-altered cis-regulation. Our comprehensive and pan-histology genomic analyses reveal SSVs to play a major role in shaping the transcriptome of pediatric brain tumors.


Sign in / Sign up

Export Citation Format

Share Document